Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N methyl 3 hydroxyl 3 (2 thienyl) propylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103214452B details a novel iron-mediated reduction route for duloxetine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel NHC-Cu catalyzed route for Duloxetine intermediate offers high yield and purity. Cost-effective manufacturing solution for pharmaceutical supply chains.